All data are based on the daily closing price as of March 24, 2026
y

Yuhan

000100.KO
63.79 USD
1.98
+3.20%

Overview

Last close
63.79 usd
Market cap
4.70B usd
52 week high
119.95 usd
52 week low
61.81 usd
Target price
98.13 usd

Valuation

P/E
N/A
Forward P/E
38.1679
Price/Sales
3.2721
Price/Book Value
3.2524
Enterprise Value
4.97B usd
EV/Revenue
3.4058
EV/EBITDA
24.2393

Key financials

Revenue TTM
1.46B usd
Gross Profit TTM
486.17M usd
EBITDA TTM
116.42M usd
Earnings per Share
N/A usd
Dividend
0.4 usd
Total assets
2.23B usd
Net debt
N/A usd

About

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperlipidemics, and anti-hypertensive; and custom synthesis services through commercial supply in areas of anti-viral, anti-HIV, anti-HCV, anti-biotic, antihistamine, anti-diabetic, ß-lactamase inhibitor, CNS intermediate, PEG-compounds, and others. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.
  • Symbol
    000100.KO
  • Exchange
    KO
  • Isin
    KR7000100008
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Wook-Je Cho
  • Headquarter
    Seoul
  • Web site
    https://www.yuhan.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top